siRNA-Mediated Silencing in Cell Lines
Cell line | Tissue origin | Reference |
---|---|---|
A-431 | human epidermoid carcinoma | (23) |
A549 | human lung carcinoma | (72) |
BV173 | human B-precursor leukemia | (77) |
C-33A | human papilloma virus negative cervical carcinoma | (46) |
CA46 | human Burkitt’s lymphoma | (77) |
Caco2 | human colon epithelial cells | (61) |
CHO | Chinese hamster ovary | (23) |
COS-7 | African green monkey kidney | (9) |
F5 | rat fibroblast | (32) |
H1299 | human nonsmall cell lung carcinoma | (46) |
HaCaT | human keratinocyte cell | (12) |
HEK 293 | human embryonic kidney | (9) |
HeLa | human papilloma virus positive cervical carcinoma | (9) |
Hep3B | human hepatocellular carcinoma | (64) |
HUVEC | human umbilical vein endothelial cells | (54) |
IMR-90 | human diploid fibroblast | (41) |
K562 | human chronic myelogenous leukemia, blast crisis | (77) |
Karpas 299 | human T-cell lymphoma | (77) |
MCF-7 | human breast cancer | (84) |
MDA-MB-468 | human breast cancer | (84) |
MV-411 | human acute monocytic leukemia | (77) |
NIH/3T3 | mouse fibroblast | (9) |
P19 | mouse embryonic carcinoma | (42) |
SD1 | human acute lymphoblastic leukemia | (77) |
SKBR3 | human breast cancer | (23) |
U2OS | human osteogenic sarcoma cell | (59) |